Bayer has settled a class action lawsuit regarding claims that Monsanto’s weedkiller Roundup caused non-Hodgkin’s lymphoma. The settlement includes the lawsuits from the federal multidistrict litigation and state of California. The deal includes an estimated range of $8.8-$9.6 billion for current lawsuits and an additional $1.25 billion to provide relief for potential future plaintiffs who may develop an illness but are not current plaintiffs.

In addition to the Roundup settlement, Bayer also reached a settlement of $400 million in the dicamba drift cases and approximately $820 million in some of the PCB contamination lawsuits brought by public entities.

Bayer purchased Monsanto in 2018.

Composition with bread and rolls isolated on whiteGlyphosate, the active ingredient in Monsanto’s Roundup® herbicide, was reported to be “the most important causal factor” in the worldwide increase of gluten intolerance and celiac disease, according to a paper written by MIT scientist Stephanie Seneff and Dr. Anthony Samsel and published by the Journal of Interdisciplinary Toxicology.

Continue reading “Monsanto’s Roundup connected to gluten intolerance”